South Korean pharmaceutical firm Hugel recently completed a specialized training program in Taiwan for medical professionals, reinforcing its commitment to the Asia-Pacific aesthetic market[[1]]. The event, part of Hugel’s ‘GLAM’ program launched in 2022, focused on advanced techniques for administering the company’s botulinum toxin and dermal filler products[[1]]. This training reflects a broader trend of international companies investing in localized education to support the growth of cosmetic surgery and aesthetic medicine globally[[2]].
Hugel Hosted Training for Taiwanese Medical Professionals
South Korean pharmaceutical company Hugel recently conducted a training session for doctors from Taiwan, focusing on the use of its botulinum toxin and dermal filler products. The event underscores the company’s growing international reach in the aesthetic medicine market.
The training, held for Taiwanese medical professionals, covered techniques for administering Hugel’s botulinum toxin and filler lines. Participants received instruction on optimal injection methods and best practices for patient care.
Hugel has been actively expanding its presence in the global aesthetics market, and this training initiative is part of that strategy. The company aims to provide healthcare providers with the knowledge and skills needed to effectively utilize its products, ultimately benefiting patients seeking cosmetic treatments.
